The enactment of SB3345 would lead to substantial changes in how pharmacy payments are structured under Medicaid and Medicare. It introduces a framework designed to eliminate hidden costs and enable clearer accounting of how prices are set. This includes requiring contracts between state agencies and PBMs to ensure that payments made for covered outpatient drugs reflect fair market value and that excessive pricing, particularly through spread pricing, is prohibited. Such reforms are expected to enhance pharmacy access and affordability for beneficiaries while holding PBMs accountable for their pricing practices.
Summary
SB3345, known as the PBM Price Transparency and Accountability Act, seeks to amend the Social Security Act, specifically targeting the reimbursement processes under Medicaid and Medicare. The key objectives of this bill include ensuring accurate payments to pharmacies, combating the abusive practice of spread pricing by pharmacy benefit managers (PBMs), and enhancing the transparency of drug pricing. By introducing measures such as mandatory surveys to determine national average drug acquisition costs, the bill aims to guarantee that pharmacies are fairly compensated for the drugs they dispense and that beneficiaries have clear visibility into the costs involved in their medication.
Contention
Despite its good intentions, SB3345 has faced criticism from various stakeholders. Proponents highlight its potential to prevent PBMs from profiting off the spread between acquisition costs and reimbursement prices, which can inflate costs for patients. However, opponents argue that the bill might impose excessive administrative burdens on pharmacies and PBMs and could disrupt established payment models. The debate centers around the balance of ensuring transparency and accountability without stifling pharmacy operations or increasing costs in other areas of the healthcare system.
Related
Nationwide Consumer and Fuel Retailer Choice Act Recycling and Composting Accountability Act SUPPORT for Patients and Communities Reauthorization Act of 2025 American Music Tourism Act Deploying American Blockchains Act
Related
Bipartisan Health Care Act Pandemic and All-Hazards Preparedness and Response Act SUPPORT for Patients and Communities Reauthorization Act of 2025
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).